The Journal of Medical Investigation
Online ISSN : 1349-6867
Print ISSN : 1343-1420
ISSN-L : 1343-1420
Originals
Treatment results of two-stage operation for the patients with esophageal cancer concomitant with liver dysfunction
Mitsuhiro YasudaHiroshi SaekiYuichiro NakashimaTakafumi YukayaSatoshi TsutsumiHirotada TajiriYoko ZaitsuYasuo TsudaYuta KasagiKoji AndoYu ImamuraKippei OhgakiTomohiko AkahoshiEiji OkiYoshihiko Maehara
Author information
JOURNALS FREE ACCESS

2015 Volume 62 Issue 3.4 Pages 149-153

Details
Abstract

Purpose: The aim of this study was to clarify the usefulness of two-stage operation for the patients with esophageal cancer who have liver dysfunction. Methods: Eight patients with esophageal cancer concomitant with liver dysfunction who underwent two-stage operation were analyzed. The patients initially underwent an esophagectomy, a cervical esophagostomy and a tube jejunostomy, and reconstruction with gastric tube was performed after the recovery of patients' condition. Results: The average time of the 1st and 2nd stage operation was 410.0 min and 438.9 min, respectively. The average amount of blood loss in the 1st and 2nd stage operation was 433.5 ml and 1556.8 ml, respectively. The average duration between the operations was 29.8 days. The antesternal route was selected for 5 patients (62.5%) and the retrosternal route was for 3 patients (37.5%). In the 1st stage operation, no postoperative complications were observed, while, complications developed in 5 (62.5%) patients, including 4 anastomotic leakages, after the 2nd stage operation. Pneumonia was not observed through two-stage operation. No in-hospital death was experienced. Conclusion: A two-stage operation might prevent the occurrence of critical postoperative complications for the patients with esophageal cancer concomitant with liver dysfunction. J. Med. Invest. 62: 149-153, August, 2015

Information related to the author
© 2015 by The University of Tokushima Faculty of Medicine
Previous article Next article
feedback
Top